|
CRDF | Cardiff Oncology, Inc. |
|
|
CRDF | Cardiff Oncology, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 2.16 |
| Leverage | 27.44% |
| Market Cap | $ 58.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -44.7m |
| Margin | -8603.10% |
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.